Real-Time EquityWire is available only to registered users. This is best for professional traders and people who track markets actively.Real-Time EquityWire is available only to registered users. This is best for professional traders and people who track markets actively.
A division bench of the Delhi High Court on Wednesday restored the temporary ban on the sale and marketing of Sigrima by Zydus Lifesciences Ltd. based on a plea by F-Hoffmann-LaRoche AG. Setting aside an order by a single bench, the division bench also restored the Swiss multinational Roche's plea to seek an interim injunction against Zydus Lifesciences before the single bench till the main suit is decided.
Share this Story:
